Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe related topics panel no longer lists the disease (Ovarian cancer) and the MedlinePlus Genetics link. This changes the auxiliary context and linked resources shown on the page, while core study details remain unchanged.SummaryDifference0.1%

- Check8 days agoChange DetectedThe recruitment status changed from Recruiting to Not yet recruiting. The page now lists Ovarian cancer as the condition and adds related topics, including MedlinePlus Genetics, to provide broader context.SummaryDifference0.6%

- Check16 days agoChange DetectedRemoval of the related topic links 'Ovarian cancer' and 'MedlinePlus Genetics' from the page's related topics section. This alters the navigational links but does not affect the core trial information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page version/revision label was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded topic: Ovarian cancer and related topic: MedlinePlus Genetics. Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check44 days agoChange DetectedThe ovarian cancer topic tag and the MedlinePlus Genetics related topics were removed. This could affect study categorization and access to related informational resources.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.